Gert Van Assche
Impact in
- Genetics top 0.01%
- Inflammatory Bowel Disease
- Gastroenterology top 0.1%
Papers in
- Genetics 322
- Inflammatory Bowel Disease 318
- Epidemiology 129
- Microscopic Colitis 108
- Autoimmune and Inflammatory Disorders 31
- Co-authors
- Severine A.R.A. Vermeire (251 shared papers)Paul J. Rutgeerts (138 shared papers)Marc Ferrante (173 shared papers)Maja Noman (60 shared papers)Geert D’Haens (45 shared papers)Filip J. Baert (24 shared papers)Jean Fred Colombel (24 shared papers)William J. Sandborn (31 shared papers)
- Journals
- Journal of Crohn s and Colitis (65 papers)Inflammatory Bowel Diseases (63 papers)Gastroenterology (62 papers)Gut (27 papers)Alimentary Pharmacology & Therapeutics (23 papers)
- Partner nations
- BelgiumUnited StatesCanada
In The Last Decade
Gert Van Assche
440 papers receiving 48.0k citations
Gert Van Assche's Hit Papers
Peers
Comparison fields: 5 of 155
- Genetics 33.3k
- Gastroenterology 2.6k
- Epidemiology 14.6k
- Immunology 7.2k
- Surgery 8.4k
Countries citing papers authored by Gert Van Assche
This map shows the geographic impact of Gert Van Assche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gert Van Assche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gert Van Assche more than expected).
Fields of papers citing papers by Gert Van Assche
This network shows the impact of papers produced by Gert Van Assche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gert Van Assche. The network helps show where Gert Van Assche may publish in the future.
Co-authors
The 25 scholars most cited alongside Gert Van Assche, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 448 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis Hit paper breakdown → | 2013 | 2390 |
| 2 | Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease Hit paper breakdown → | 2003 | 1737 |
| 3 | 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical Management Hit paper breakdown → | 2016 | 1619 |
| 4 | Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target Hit paper breakdown → | 2015 | 1517 |
| 5 | Development and validation of a new, simplified endoscopic activity score for Crohn's disease: the SES-CD Hit paper breakdown → | 2004 | 1468 |
| 6 | Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management Hit paper breakdown → | 2012 | 1357 |
| 7 | The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management Hit paper breakdown → | 2010 | 1247 |
| 8 | The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis Hit paper breakdown → | 2010 | 1137 |
| 9 | Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis Hit paper breakdown → | 2011 | 1070 |
| 10 | Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial Hit paper breakdown → | 2008 | 1038 |
| 11 | Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis Hit paper breakdown → | 2019 | 948 |
| 12 | Progressive Multifocal Leukoencephalopathy after Natalizumab Therapy for Crohn's Disease Hit paper breakdown → | 2005 | 882 |
| 13 | Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial Hit paper breakdown → | 2016 | 849 |
| 14 | Trough Concentrations of Infliximab Guide Dosing for Patients With Inflammatory Bowel Disease Hit paper breakdown → | 2015 | 732 |
| 15 | Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis Hit paper breakdown → | 2012 | 726 |
| 16 | The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations Hit paper breakdown → | 2009 | 719 |
| 17 | Mucosal Healing Predicts Sustained Clinical Remission in Patients With Early-Stage Crohn's Disease Hit paper breakdown → | 2009 | 708 |
| 18 | Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease Hit paper breakdown → | 2012 | 687 |
| 19 | Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohnʼs disease Hit paper breakdown → | 2009 | 591 |
| 20 | Imaging techniques for assessment of inflammatory bowel disease: Joint ECCO and ESGAR evidence-based consensus guidelines Hit paper breakdown → | 2013 | 534 |
About Gert Van Assche
Gert Van Assche is a scholar working on Genetics, Epidemiology, Immunology, Gastroenterology and Surgery, having authored 448 papers that have together received 49.4k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (318 papers), Microscopic Colitis (108 papers), Autoimmune and Inflammatory Disorders (31 papers), Immunodeficiency and Autoimmune Disorders (30 papers), Helicobacter pylori-related gastroenterology studies (20 papers), Celiac Disease Research and Management (20 papers), Diverticular Disease and Complications (18 papers) and Liver Diseases and Immunity (12 papers). The work is most often cited by research in Genetics (33.3k citations), Gastroenterology (2.6k citations), Epidemiology (14.6k citations), Immunology (7.2k citations) and Surgery (8.4k citations). Gert Van Assche has collaborated with scholars based in Belgium, United States and Canada. Frequent co-authors include Severine A.R.A. Vermeire, Paul J. Rutgeerts, Marc Ferrante, Maja Noman, Geert D’Haens, Filip J. Baert, Jean Fred Colombel, William J. Sandborn, Paul Rutgeerts and Axel U Dignass. Their work appears in journals such as Journal of Crohn s and Colitis, Inflammatory Bowel Diseases, Gastroenterology, Gut and Alimentary Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.